MAZ is known to modulate PPARgamma1 (the peroxisome proliferator-activated receptor gamma 1) and down-regulation of PPARgamma1 directly, or via down-regulation of MAZ, was shown to inhibit cell growth and to induce apoptosis in MCF-7 breast cancer cells [44]. Here, MAZ is linked to breast carcinoma.